核心實驗室公司
DE ˙ DB ˙ US21867A1051
€11.00 ↓ -0.50 (-4.35%)
2026-06-05
分享價格
SecurityDE:HJ1 / Core Laboratories Inc.
InstitutionConnable Office Inc
Latest Disclosed Ownership14,266 shares
Latest Disclosed Value $ 239,526
Connable Office Inc reports 9.48% decrease in ownership of HJ1 / Core Laboratories Inc.

On April 29, 2026 - Connable Office Inc filed a 13F-HR form disclosing ownership of 14,266 shares of Core Laboratories Inc. (DE:HJ1) valued at $205,430 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 15,760 shares of Core Laboratories Inc.. This represents a change in shares of -9.48% during the quarter. The current value of the position is $156,926 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F Core Laboratories Com 21867A105 14,266 -1,494 -9.48 240 -5.16 0.0236
2026-02-03 2025-12-31 13F Core Laboratories Com 21867A105 15,760 15,760 253 0.0232
2025-11-06 2025-09-30 13F Core Laboratories Com 21867A105 0 -16,445 -100.00 0 -100.00
2025-08-05 2025-06-30 13F Core Laboratories Com 21867A105 16,445 0 0.00 189 -23.17 0.0187
2025-05-09 2025-03-31 13F Core Laboratories Com 21867A105 16,445 0 0.00 247 -13.38 0.0262
2025-02-05 2024-12-31 13F Core Laboratories Com 21867A105 16,445 -348 -2.07 285 -8.68 0.0295
2024-11-06 2024-09-30 13F Core Laboratories Com 21867A105 16,793 2,569 18.06 311 7.99 0.0313
2024-08-07 2024-06-30 13F Core Laboratories Com 21867A105 14,224 0 0.00 289 19.01 0.0311
2024-04-30 2024-03-31 13F Core Laboratories Com 21867A105 14,224 296 2.13 243 -1.22 0.0275
2024-02-12 2023-12-31 13F Core Laboratories Com 21867A105 13,928 0 0.00 246 -26.65 0.0298
2023-11-08 2023-09-30 13F Core Laboratories Com 21867A105 13,928 0 0.00 334 3.41 0.0459
2023-08-07 2023-06-30 13F Core Laboratories Com 21867A105 13,928 13,928 324 0.0444
2019-11-12 2019-09-30 13F Core Laboratories Com N22717107 0 -3,836 -100.00 0 -100.00
2019-08-06 2019-06-30 13F Core Laboratories Com N22717107 3,836 3,836 201 0.0369
2019-02-12 2018-12-31 13F Core Laboratories Com N22717107 0 -9,663 -100.00 0 -100.00
2018-11-06 2018-09-30 13F Core Laboratories Com N22717107 9,663 0 0.00 1,119 -8.28 0.2148
2018-08-07 2018-06-30 13F Core Laboratories Com N22717107 9,663 -483 -4.76 1,220 11.11 0.2473
2018-05-08 2018-03-31 13F Core Laboratories Com N22717107 10,146 477 4.93 1,098 3.68 0.2159
2018-02-07 2017-12-31 13F Core Laboratories Com N22717107 9,669 -1,421 -12.81 1,059 -3.29 0.2061
2017-11-03 2017-09-30 13F Core Laboratories Com N22717107 11,090 122 1.11 1,095 -1.44 0.2239
2017-08-01 2017-06-30 13F Core Laboratories Com N22717107 10,968 9,162 507.31 1,111 431.58 0.2433
2017-05-04 2017-03-31 13F Core Laboratories Com N22717107 1,806 -2,514 -58.19 209 -59.73 0.0471
2017-02-08 2016-12-31 13F Core Laboratories Com N22717107 4,320 -13,120 -75.23 519 -73.51 0.1191
2016-11-08 2016-09-30 13F Core Laboratories Com N22717107 17,440 2,160 14.14 1,959 3.49 0.4672
2016-08-04 2016-06-30 13F Core Laboratories Com N22717107 15,280 -1,168 -7.10 1,893 2.38 0.5284
2016-05-09 2016-03-31 13F Core Laboratories Com N22717107 16,448 -73 -0.44 1,849 2.95 0.5120
2016-02-11 2015-12-31 13F Core Laboratories Com N22717107 16,521 -138 -0.83 1,796 8.00 0.5167
2015-11-12 2015-09-30 13F Core Laboratories Com N22717107 16,659 -1,063 -6.00 1,663 -17.71 0.4934
2015-08-05 2015-06-30 13F Core Laboratories Com N22717107 17,722 11,237 173.28 2,021 198.08 0.5398
2015-04-30 2015-03-31 13F Core Laboratories Com N22717107 6,485 -275 -4.07 678 -16.61 0.1733
2015-02-10 2014-12-31 13F Core Laboratories Com N22717107 6,760 -280 -3.98 813 -21.07 0.2190
2014-11-12 2014-09-30 13F Core Laboratories Com N22717107 7,040 -20 -0.28 1,030 -12.64 0.2703
2014-07-22 2014-06-30 13F Core Laboratories Com N22717107 7,060 -735 -9.43 1,179 -23.79 0.3041
2014-05-06 2014-03-31 13F Core Laboratories Com N22717107 7,795 -250 -3.11 1,547 0.72 0.4207
2014-01-13 2013-12-31 13F Core Laboratories Com N22717107 8,045 -1,589 -16.49 1,536 -5.77 0.4162
2013-10-24 2013-09-30 13F Core Laboratories Com N22717107 9,634 206 2.18 1,630 13.99 0.4588
2013-07-23 2013-06-30 13F Core Laboratories Com N22717107 9,428 9,428 1,430 0.4079
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.